Nathaniel Greer
The US Food and Drug Administration (FDA) has recently taken steps to promote the advancement of decentralized clinical trials (DCTs), recognizing the potential to improve patient access and participation. As the VP of Compliance at Datacubed Health, I would like to share our analysis of these developments and offer recommendations to sponsors, CROs, and sites …
Embracing New Horizons in Clinical Trial Technology As clinical trials continue to evolve, technology plays an increasingly important role in shaping the future of research. Innovations in technology enable more efficient processes, improved data accuracy, and also better patient outcomes. In this article, we’ll discuss the future of clinical trial technology compliance. And the potential …
With recent EU regulatory recommendations made around DCTs, here’s everything you need to know. The European Union (EU) recently issued new regulatory recommendations for Decentralized Clinical Trials. This will significantly impact clinical research in the region. The recommendations reflect the EU’s efforts to embrace the latest digital technologies. Improving efficiency and effectiveness of clinical trials …